COVID-19 Vaccine: Nigeria to adopt “whole family” approach in second phase
The National Primary Health Care Development Agency (NPHCDA) has announced plans to adopt “the whole family” approach in the second phase of the COVID-19 vaccination in order to integrate the exercise into other basic Primary Health Care (PHC) services.
The exercise would cover PHC services like childhood vaccination, screening for hypertension, diabetes and malnutrition.
The Executive Director of NPHCDA, Dr Faisal Shuaib, disclosed this at a news conference on Tuesday in Abuja.
Shuaib said that this would ensure that while protecting eligible Nigerians against COVID-19, the agency also would be concerned about the total health of individuals and their entire family.
The executive director added that this would further enhance acceptability of the COVID-19 vaccine across the country.
“We are adopting ‘the whole family approach’ to integrate the COVID-19 vaccination with other basic PHC services such as childhood vaccination, screening for hypertension, diabetes, malnutrition.
“We will give residents another opportunity to listen to NPHCDA, State Primary Health Care Development Agency (SPHCDA) and the State Ministry of Health (SMoH) on how they can improve on personal hygiene, water and environmental sanitation.
“This is particularly important in view of the large number of cases of cholera that we are recording across the country,” he explained.
He disclosed that the agency had met with the Director General, National Agency for Food and Drug Administration and Control (NAFDAC), Dr Mojisola Adeyeye, to finalise discussion on how to continue the collaboration that led to effective vaccine monitoring and accountability experienced in the first phase of the COVID-19 roll out.
He added that this was effected using ‘track and trace’, an innovative approach first used in Nigeria during the first COVID-19 vaccination roll out.
He said that this was why first phase of the vaccination exercise was declared finished on July 9, as there was no available vaccines in the country, adding that “this kind of accountability is what we want to replicate in the second phase rollout.
“This is as a result of the leadership provided by the Presidential Steering Committee (PSC), FMoH, NAFDAC, NCDC and of course the NPHCDA,” he said.
According to him, the reason why we had to extend/postpone the launch date of the vaccine is because we want to institute once again, in conjunction with NAFDAC, the track and trace all the way to health facility where the vaccines would be administered.
He explained that the agency was locally creating labels for the vaccines barcode that would ensure that the tracking and tracing continued like it did in the first phase.
Speaking on the brands of COVID-19 vaccines available in Nigeria, he said that as of Aug. 10, 2021, the country had received 4,000,080 doses of the Moderna COVID-19 vaccine, donated by Government of the United States of America.
He, however, said that the country was expecting additional vaccines between August and September 2021, including Oxford AstraZeneca, Johnson & Johnson, Moderna and Pfizer.
Shuaib stated that while the agency was hopeful and well-prepared to roll out the second phase vaccination plan, it was by no means oblivious of the fact that there were challenges ahead, especially now that the country had started receiving different brands of COVID-19 vaccines.
“We are aware that Nigerians would want to know if there is a preferred brand. Let me assure everyone that COVID-19 vaccines, regardless of brand, as long as they have been approved by NAFDAC, provide adequate protection against the disease.
“We want to further assure Nigerians that we have strategised with our partners so that there is no confusion on which vaccines will be given to whom.
“For example, all those who have taken their first dose of AstraZeneca vaccines and are due for their 2nd dose would be given their second dose in this month of August as we are expecting up to 588,800 doses of the AstraZeneca vaccine from the COVAX facility.
“This is the first batch that will be coming in the next couple of days, thereafter we will be expecting up to 3.9 million doses of the AstraZeneca vaccines to complement what we already have and to make sure we cover not only those who will be taking their second AstraZeneca vaccine but also for those who will want to take their 1st dose of this vaccine.
“In all communications, we have been clear that the AstraZeneca and Moderna vaccines are very effective against the Delta variant as cases are beginning to increase in states like Lagos and Akwa Ibom,” he said.
